Home / business / Johnson & Johnson Stock Jumps 8% on Plans to Conduct Human Trials for COVID-19 Vaccine by September

Johnson & Johnson Stock Jumps 8% on Plans to Conduct Human Trials for COVID-19 Vaccine by September

-
The pharmaceutical company has signed an agreement with the US government's Biomedical Advanced Research and Development Authority to invest $1 billion in the effort, it said in a statement on Monday.

from Top Business News- News18.com
Read The Rest:timesnownews...
Johnson & Johnson Stock Jumps 8% on Plans to Conduct Human Trials for COVID-19 Vaccine by September Johnson & Johnson Stock Jumps 8% on Plans to Conduct Human Trials for COVID-19 Vaccine by September Reviewed by Team Exprssnews on March 31, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.